Dechra Pharmaceuticals PLC
DCHPF · OTC
6/30/2023 | 6/30/2022 | 6/30/2021 | 6/30/2020 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $74 | $121 | $118 | $227 |
| Short-Term Investments | $0 | $0 | $0 | $0 |
| Receivables | $144 | $122 | $88 | $79 |
| Inventory | $217 | $176 | $150 | $121 |
| Other Curr. Assets | $32 | $26 | $36 | $21 |
| Total Curr. Assets | $468 | $444 | $392 | $449 |
| Property Plant & Equip (Net) | $159 | $100 | $87 | $76 |
| Goodwill | $335 | $245 | $236 | $254 |
| Intangibles | $588 | $485 | $480 | $438 |
| Long-Term Investments | $15 | $16 | $17 | $17 |
| Tax Assets | $5 | $2 | $2 | $3 |
| Other NC Assets | $0 | $0 | $0 | $0 |
| Total NC Assets | $1,102 | $849 | $822 | $789 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $1,569 | $1,293 | $1,214 | $1,238 |
| Liabilities | – | – | – | – |
| Payables | $43 | $46 | $35 | $35 |
| Short-Term Debt | $4 | $3 | $3 | $5 |
| Tax Payable | $12 | $12 | $17 | $26 |
| Deferred Revenue | $12 | $12 | $17 | $26 |
| Other Curr. Liab. | -$7 | -$6 | $6 | -$17 |
| Total Curr. Liab. | $164 | $159 | $156 | $137 |
| LT Debt | $501 | $326 | $316 | $350 |
| Deferred Rev, NC | $2 | $2 | $4 | $3 |
| Deferred Tax Liab, NC | $76 | $36 | $49 | $63 |
| Other NC Liab. | $72 | $104 | $58 | $47 |
| Total NC Liab. | $650 | $468 | $425 | $463 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $0 | $0 | $0 | $0 |
| Total Liabilities | $814 | $627 | $581 | $600 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $0 |
| Common Stock | $1 | $1 | $1 | $1 |
| Retained Earnings | $87 | $164 | $148 | $126 |
| AOCI | $0 | $0 | $0 | $0 |
| Other Equity | -$88 | -$165 | -$149 | -$128 |
| Total Equity | $755 | $667 | $633 | $638 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $1,569 | $1,293 | $1,214 | $1,238 |
| Net Debt | $430 | $208 | $200 | $128 |